Latest news with #DaveBourdon
Yahoo
28-05-2025
- Business
- Yahoo
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference
SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in Miami, Florida. Details of the presentation are as follows:Presenters: Dave Bourdon, CEO, and Ryan McGroarty, CFODate: Tuesday, June 10, 2025 Time: 10:40 a.m. (Eastern time)Moderated by: Jamie Perse The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website ( A replay of the webcast will be available after the conclusion of the event and can be accessed on the LifeStance Health Investor Relations website. About LifeStance HealthFounded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation's largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental health care. LifeStance and its supported practices employ approximately 7,500 psychiatrists, advanced practice nurses, psychologists and therapists and operate across 33 states and more than 550 centers. To learn more, please visit CONTACT: Investor Contact: Monica Prokocki VP of Finance and Investor Relations Media Contact: Brooke Matthews Sr. Director of Communications media@
Yahoo
28-05-2025
- Business
- Yahoo
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference
SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in Miami, Florida. Details of the presentation are as follows:Presenters: Dave Bourdon, CEO, and Ryan McGroarty, CFODate: Tuesday, June 10, 2025 Time: 10:40 a.m. (Eastern time)Moderated by: Jamie Perse The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website ( A replay of the webcast will be available after the conclusion of the event and can be accessed on the LifeStance Health Investor Relations website. About LifeStance HealthFounded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation's largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental health care. LifeStance and its supported practices employ approximately 7,500 psychiatrists, advanced practice nurses, psychologists and therapists and operate across 33 states and more than 550 centers. To learn more, please visit CONTACT: Investor Contact: Monica Prokocki VP of Finance and Investor Relations Media Contact: Brooke Matthews Sr. Director of Communications media@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-05-2025
- Business
- Yahoo
LifeStance Health Group's (NASDAQ:LFST) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations
Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street's revenue expectations in Q1 CY2025, with sales up 10.8% year on year to $333 million. On the other hand, next quarter's revenue guidance of $342 million was less impressive, coming in 2.7% below analysts' estimates. Its GAAP loss of $0 per share was significantly above analysts' consensus estimates. Is now the time to buy LifeStance Health Group? Find out in our full research report. LifeStance Health Group (LFST) Q1 CY2025 Highlights: Revenue: $333 million vs analyst estimates of $333.5 million (10.8% year-on-year growth, in line) EPS (GAAP): $0 vs analyst estimates of -$0.03 (significant beat) Adjusted EBITDA: $34.65 million vs analyst estimates of $30.23 million (10.4% margin, 14.6% beat) The company reconfirmed its revenue guidance for the full year of $1.42 billion at the midpoint EBITDA guidance for the full year is $140 million at the midpoint, in line with analyst expectations Operating Margin: 0.5%, up from -5.6% in the same quarter last year Free Cash Flow was -$10.26 million compared to -$26.94 million in the same quarter last year Sales Volumes rose 9.7% year on year (15.2% in the same quarter last year) Market Capitalization: $2.55 billion 'We delivered a solid quarter to kick off 2025, thanks to the commitment and dedication of our employees, including over 7,500 clinicians,' said Dave Bourdon, CEO of LifeStance. Company Overview With over 6,600 licensed mental health professionals treating more than 880,000 patients annually, LifeStance Health (NASDAQ:LFST) provides outpatient mental health services through a network of clinicians offering psychiatric evaluations, psychological testing, and therapy across 33 states. Sales Growth A company's long-term sales performance is one signal of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Luckily, LifeStance Health Group's sales grew at an incredible 39.2% compounded annual growth rate over the last five years. Its growth beat the average healthcare company and shows its offerings resonate with customers. LifeStance Health Group Quarterly Revenue We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. LifeStance Health Group's annualized revenue growth of 18.8% over the last two years is below its five-year trend, but we still think the results suggest healthy demand. LifeStance Health Group Year-On-Year Revenue Growth We can better understand the company's revenue dynamics by analyzing its number of clinicians, which reached 7,535 in the latest quarter. Over the last two years, LifeStance Health Group's clinicians averaged 14.7% year-on-year growth. Because this number is lower than its revenue growth, we can see the company benefited from price increases.
Yahoo
03-03-2025
- Business
- Yahoo
March 2025 Growth Companies With Strong Insider Confidence
As the U.S. stock market grapples with economic uncertainties and fluctuating indices, investors are keenly observing insider activity as a potential signal of confidence in company prospects. In this environment, growth companies with high insider ownership may offer insights into where those closely connected to the business see long-term value, making them noteworthy considerations for investors seeking resilient opportunities amid current challenges. Name Insider Ownership Earnings Growth Atour Lifestyle Holdings (NasdaqGS:ATAT) 26% 25.6% Super Micro Computer (NasdaqGS:SMCI) 14.2% 29.1% Corcept Therapeutics (NasdaqCM:CORT) 11.7% 36.7% Hims & Hers Health (NYSE:HIMS) 13.2% 21.8% Kingstone Companies (NasdaqCM:KINS) 17.7% 24.2% On Holding (NYSE:ONON) 19.1% 29.6% Astera Labs (NasdaqGS:ALAB) 16.1% 61.1% BBB Foods (NYSE:TBBB) 16.5% 41.1% Upstart Holdings (NasdaqGS:UPST) 12.7% 100.1% Credit Acceptance (NasdaqGS:CACC) 14.4% 33.6% Click here to see the full list of 202 stocks from our Fast Growing US Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★☆☆ Overview: LifeStance Health Group, Inc. operates through its subsidiaries to offer outpatient mental health services across various age groups in the United States, with a market cap of approximately $2.99 billion. Operations: The company generates revenue of $1.25 billion from providing outpatient mental health services to diverse age groups in the United States. Insider Ownership: 12.4% LifeStance Health Group is experiencing leadership changes with Dave Bourdon taking over as CEO, bringing extensive healthcare experience. The company reported 2024 sales of US$1.25 billion, up from US$1.06 billion the previous year, while reducing its net loss significantly. Revenue growth is projected at 13% annually, outpacing the broader US market's growth rate of 8.5%. Despite low return on equity forecasts and no recent insider trading activity, LifeStance aims for profitability within three years. Click here and access our complete growth analysis report to understand the dynamics of LifeStance Health Group. Our valuation report here indicates LifeStance Health Group may be overvalued. Simply Wall St Growth Rating: ★★★★☆☆ Overview: HCI Group, Inc., along with its subsidiaries, operates in the property and casualty insurance, insurance management, reinsurance, real estate, and information technology sectors primarily in Florida and has a market cap of approximately $1.42 billion. Operations: HCI Group's revenue streams include property and casualty insurance, insurance management, reinsurance, real estate, and information technology operations in Florida. Insider Ownership: 15.8% HCI Group's earnings are forecast to grow 14.53% annually, surpassing the US market's average growth rate. Despite a recent dip in quarterly revenue and net income, full-year revenue rose from US$550.67 million to US$750.05 million, with net income increasing as well. The company maintains a favorable price-to-earnings ratio of 13.4x compared to the market's 17.9x, indicating potential value for investors focused on growth companies with substantial insider ownership. Unlock comprehensive insights into our analysis of HCI Group stock in this growth report. Insights from our recent valuation report point to the potential overvaluation of HCI Group shares in the market. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Jefferies Financial Group Inc. is an investment banking and capital markets firm with operations across the Americas, Europe, the Middle East, and Asia-Pacific, boasting a market cap of approximately $13.65 billion. Operations: Jefferies Financial Group Inc. generates revenue primarily from its Investment Banking and Capital Markets segment, which accounts for $6.20 billion, and its Asset Management segment, contributing $803.70 million. Insider Ownership: 20.3% Jefferies Financial Group's earnings are projected to grow significantly at 25% annually, outpacing the US market's average. Despite a dividend yield of 2.42% not being fully covered by free cash flows, its price-to-earnings ratio of 20.5x remains below the industry average, suggesting relative value. Recent fixed-income offerings totaling over US$800 million indicate strategic capital management efforts, supporting growth initiatives and potentially enhancing shareholder value through increased financial flexibility. Take a closer look at Jefferies Financial Group's potential here in our earnings growth report. According our valuation report, there's an indication that Jefferies Financial Group's share price might be on the cheaper side. Investigate our full lineup of 202 Fast Growing US Companies With High Insider Ownership right here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include NasdaqGS:LFST NYSE:HCI and NYSE:JEF. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
